• Peter PanizziEmail author
  • Heather K. Kroh
  • Pablo Fuentes-Prior
  • Paul E. Bock


Staphylocoagulase (SC) is a protein secreted by most strains of Staphylococcus aureus, a potent human pathogenic bacterium. SC causes blood clotting by direct activation of the thrombin precursor, prothrombin (ProT). This occurs through a non-proteolytic, cofactor-induced mechanism of activation called “molecular sexuality”. The 2.2 Å crystal structure of a fully active SC fragment in complex with the ProT catalytic domain, prethrombin 2, proved the molecular sexuality mechanism. Recent structural and mechanistic studies have investigated how SC specifically activates ProT to cause fibrin generation through association of active SC·ProT* complexes with fibrinogen. In addition, a predicted structural homolog of SC has been identified from S. aureus, called von Willebrand factor-binding protein (VWbp). VWbp also activates human ProT by the molecular sexuality mechanism, but it displays additional regulation of its specificity through a novel hysteretic kinetic mechanism. The mechanisms used by both of these bacterial ProT activators to subvert the human coagulation system offers new insight into the role of secreted exoproteins in staphylococcal infection, as well as alternative pathways for targeted treatment of staphylococcal coagulopathies.


Fibrinogen Binding Free Thrombin Bovine Trypsinogen Thrombin Precursor Human ProT 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Research from the authors’ laboratories was supported by National Institutes of Health Grant R37 HL071544 from the Heart, Lung, and Blood Institute to P. E. B., F32 HL094010 and K99 HL094533 to P. P., and SAF2007-64140 from Spanish Ministerio de Ciencia e Innovación (MICINN) to P. F.-P. H.K.K. was supported in part by NIH Training Grant T32 HL07751.


  1. Anderson, P.J., Nesset, A., Dharmawardana, K.R., Bock, P.E., 2000. Characterization of proexosite I on prothrombin. J. Biol. Chem. 275, 16428–16434.PubMedCrossRefGoogle Scholar
  2. Baddour, L.M., 1996. A trojan horse mechanism in the pathogenesis of infective endocarditis: a hypothesis. Zentralbl. Bakteriol. 283, 266–270.PubMedCrossRefGoogle Scholar
  3. Baddour, L.M., Tayidi, M.M., Walker, E., McDevitt, D., Foster, T.J., 1994. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J. Med. Microbiol. 41, 259–263.PubMedCrossRefGoogle Scholar
  4. Binnie, C.G., Lord, S.T., 1993. The fibrinogen sequences that interact with thrombin. Blood 81, 3186–3192.PubMedGoogle Scholar
  5. Bjerketorp, J., Jacobsson, K., Frykberg, L., 2004. The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol. Lett. 234, 309–314.PubMedCrossRefGoogle Scholar
  6. Bjerketorp, J., Nilsson, M., Ljungh, A., Flock, J.I., Jacobsson, K., Frykberg, L., 2002. A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148, 2037–2044.PubMedGoogle Scholar
  7. Blobel, H., Berman, D.T., Simon, J., 1960. Purification of staphylococcal coagulase. J. Bacteriol. 79, 807–815.PubMedGoogle Scholar
  8. Bode, W., Fehlhammer, H., Huber, R., 1976. Crystal structure of bovine trypsinogen at 1.8 Å resolution. I. Data collection, application of Patterson search techniques and preliminary structural interpretation. J. Mol. Biol. 106, 325–335.PubMedCrossRefGoogle Scholar
  9. Bode, W., Huber, R., 1976. Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin. FEBS Lett. 68, 231–236.PubMedCrossRefGoogle Scholar
  10. Bode, W., Schwanger, P., Huber, R., 1978. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding: the refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 Å resolution. J. Mol. Biol. 118, 99–112.PubMedCrossRefGoogle Scholar
  11. Burlak, C., Hammer, C.H., Robinson, M.A., Whitney, A.R., McGavin, M.J., Kreiswirth, B.N., Deleo, F.R., 2007. Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol. 9, 1172–1190.PubMedCrossRefGoogle Scholar
  12. Cabell, C.H., Fowler, V.G., Jr., 2004. Repeated echocardiography after the diagnosis of endocarditis: too much of a good thing? Heart 90, 975–976.PubMedCrossRefGoogle Scholar
  13. Chapman, G.H., Berens, C., Peters, A., Curcio, L., 1934. Coagulase and hemolysin tests as measures of the pathogenicity of Staphylococci. J. Bacteriol. 28, 343–363.PubMedGoogle Scholar
  14. Downing, M.R., Butkowski, R.J., Clark, M.M., Mann, K.G., 1975. Human prothrombin activation. J. Biol. Chem. 250, 8897–8906.PubMedGoogle Scholar
  15. Drummond, M.C., Tager, M., 1962. Enzymatic activities associated with clotting of fibrinogen by staphylocoagulase and coagulase-reacting factor and their inhibition by disopropylfluophosphate. J. Bacteriol. 83, 975–980.PubMedGoogle Scholar
  16. Durack, D. 2001. Infective and noninfective endocarditis, in: Hurst, J.W., Sonnenblick, E.H., Wenger, N.K. (Eds.), The Heart: Arteries and Veins (vol. 63). McGraw-Hill, New York, pp. 1230–1255.Google Scholar
  17. Durack, D.T., 1975. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J. Pathol. 115, 81–89.PubMedCrossRefGoogle Scholar
  18. Duthie, E.S., Haughton, G., 1958. Purification of free staphylococcal coagulase. Biochem. J. 70, 125–134.PubMedGoogle Scholar
  19. Esmon, C.T., Owen, W.G., Jackson, C.M., 1974. The conversion of prothrombin to thrombin II. Differentiation between thrombin- and factor Xa-catalyzed proteolyses. J. Biol. Chem. 249, 606–611.PubMedGoogle Scholar
  20. Freer, S.T., Kraut, J., Robertus, J.D., Wright, H.T., Xuong, N.H., 1970. Chymotrypsinogen: 2.5 Å crystal structure, comparison with α-chymotrypsinogen, and implications for zymogen activation. Biochemistry 9, 1997–2009.PubMedCrossRefGoogle Scholar
  21. Frieden, C., 1970. Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept. J. Biol. Chem. 245, 5788–5799.PubMedGoogle Scholar
  22. Friedrich, R., Panizzi, P., Fuentes-Prior, P., Richter, K., Verhamme, I., Anderson, P.J., Kawabata, S., Huber, R., Bode, W., Bock, P.E., 2003. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425, 535–539.PubMedCrossRefGoogle Scholar
  23. Friedrich, R., Panizzi, P., Kawabata, S., Bode, W., Bock, P.E., Fuentes-Prior, P., 2006. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation. J. Biol. Chem. 281, 1188–1195.PubMedCrossRefGoogle Scholar
  24. Gotz, F., Ahrne, S., Lindberg, M., 1981. Plasmid transfer and genetic recombination by protoplast fusion in staphylococci. J. Bacteriol. 145, 74–81.PubMedGoogle Scholar
  25. Haraldsson, I., Jonsson, P., 1984. Histopathology and pathogenesis of mouse mastitis induced with Staphylococcus aureus mutants. J. Comp. Pathol. 94, 183–196.PubMedCrossRefGoogle Scholar
  26. Hasegawa, N., San Clemente, C.L., 1978. Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants. Infect. Immun. 22, 473–479.PubMedGoogle Scholar
  27. Heilmann, C., Herrmann, M., Kehrel, B.E., Peters, G., 2002. Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J. Infect. Dis. 186, 32–39.PubMedCrossRefGoogle Scholar
  28. Hemker, H.C., Bas, B.M., Muller, A.D., 1975. Activation of a pro-enzyme by a stoichiometric reaction with another protein: the reaction between prothrombin and staphylocoagulase. Biochim. Biophys. Acta 379, 180–188.PubMedCrossRefGoogle Scholar
  29. Hendrix, H., Lindhout, T., Mertens, K., Engels, W., Hemker, H.C., 1983. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J. Biol. Chem. 258, 3637–3644.PubMedGoogle Scholar
  30. Hijikata-Okunomiya, A., Kataoka, N., 2003. Argatroban inhibits staphylothrombin. J. Thromb. Haemost. 1, 2060–2061.PubMedCrossRefGoogle Scholar
  31. Huber, R., Bode, W., 1978. Structural basis of the activation and action of trypsin. Accts. Chem. Res. 11, 114–122.CrossRefGoogle Scholar
  32. Jonsson, P., Lindberg, M., Haraldsson, I., Wadstrom, T., 1985. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect. Immun. 49, 765–769.PubMedGoogle Scholar
  33. Kawabata, S.-I., Iwanaga, S., 1994. Structure and function of staphylothrombin. Semin. Thromb. Hemost. 20, 345–350.PubMedCrossRefGoogle Scholar
  34. Kawabata, S., Miyata, T., Morita, T., Miyata, T., Iwanaga, S., Igarashi, H., 1986a. The amino acid sequence of the procoagulant- and prothrombin-binding domain isolated from staphylocoagulase. J. Biol. Chem. 261, 527–531.PubMedGoogle Scholar
  35. Kawabata, S., Morita, T., Iwanaga, S., Igarashi, H., 1985a. Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin. J. Biochem., Tokyo 97, 1073–1078.PubMedGoogle Scholar
  36. Kawabata, S., Morita, T., Iwanaga, S., Igarashi, H., 1985b. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. J. Biochem., Tokyo 98, 1603–1614.PubMedGoogle Scholar
  37. Kawabata, S., Morita, T., Iwanaga, S., Igarashi, H., 1985c. Staphylocoagulase-binding region in human prothrombin. J. Biochem. 97, 325–331.PubMedGoogle Scholar
  38. Kawabata, S., Morita, T., Miyata, T., Iwanaga, S., Igarashi, H., 1986b. Isolation and characterization of staphylocoagulase chymotryptic fragment. Localization of the procoagulant- and prothrombin-binding domain of this protein. J. Biol. Chem. 261, 1427–1433.PubMedGoogle Scholar
  39. Kawabata, S., Morita, T., Miyata, T., Kaida, S., Igarashi, H., Iwanaga, S., 1986c. Difference in enzymatic properties between “staphylothrombin” and free alpha-thrombin. Ann. N.Y. Acad. Sci. 485, 27–40.PubMedCrossRefGoogle Scholar
  40. Kay, J., Kassell, B., 1971. The autoactivation of trypsinogen. J. Biol. Chem. 246, 6661–6665.PubMedGoogle Scholar
  41. Khan, A.R., James, M.N.G., 1998. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7, 815–836.PubMedCrossRefGoogle Scholar
  42. Korzeniowski, O., Kaye, D. 1992. Infective endocarditis, in: Braunwald, E., (Ed.), Heart Disease. A Textbook of Cardiovascular Medicine. W.B. Saunders, Philadelphia, pp. 1078–1105.Google Scholar
  43. Kroh, H.K., Panizzi, P., Bock, P.E., 2009. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc. Natl. Acad. Sci. U.S.A. 106, 7786–7791.PubMedCrossRefGoogle Scholar
  44. Loeb, L., 1903. The influence of certain bacteria on the coagulation of the blood. J. Med. Res. 10, 407–419.PubMedGoogle Scholar
  45. Masuda, S., 1983. An efficient method for the isolation of a mutant with an extremely low producibility of coagulase from a Staphylococcus aureus strain. Microbiol. Immunol. 27, 801–805.PubMedGoogle Scholar
  46. Meenan, N.A., Visai, L., Valtulina, V., Schwarz-Linek, U., Norris, N.C., Gurusiddappa, S., Hook, M., Speziale, P., Potts, J.R., 2007. The tandem beta-zipper model defines high affinity fibronectin-binding repeats within Staphylococcus aureus FnBPA. J. Biol. Chem. 282, 25893–25902.PubMedCrossRefGoogle Scholar
  47. Miale, J.B., 1949a. The role of staphylocoagulase in blood coagulation; coagulation in the absence of calcium and in the presence of fluorides, heparin, and azo dyes. Blood 4, 1317–1322.PubMedGoogle Scholar
  48. Miale, J.B., 1949b. The role of staphylocoagulase in blood coagulation; the reaction of staphylocoagulase with coagulase-globulin to form coagulase-thrombin. Blood 4, 1039–1048.PubMedGoogle Scholar
  49. Moreillon, P., Entenza, J.M., Francioli, P., McDevitt, D., Foster, T.J., Francois, P., Vaudaux, P., 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63, 4738–4743.PubMedGoogle Scholar
  50. Morgan, P.H., Robinson, N.C., Walsh, K.A., Neurath, H., 1972. Inactivation of bovine trypsinogen and chymotrypsinogen by diisopropylphosphorofluoridate. Proc. Natl. Acad. Sci. U.S.A. 69, 3312–3316.PubMedCrossRefGoogle Scholar
  51. Murray, M., Gohdes, P., 1960. Purification of staphylococcal coagulase. Biochim. Biophys. Acta 40, 518–522.PubMedCrossRefGoogle Scholar
  52. Palma, M., Shannon, O., Quezada, H.C., Berg, A., Flock, J.I., 2001. Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the α-chain. J. Biol. Chem. 276, 31691–31697.PubMedCrossRefGoogle Scholar
  53. Panizzi, P., Friedrich, R., Fuentes-Prior, P., Bode, W., Bock, P.E., 2004. The staphylocoagulase family of zymogen activator and adhesion proteins. Cell. Mol. Life Sci. 61, 2793–2798.PubMedCrossRefGoogle Scholar
  54. Panizzi, P., Friedrich, R., Fuentes-Prior, P., Kroh, H.K., Briggs, J., Tans, G., Bode, W., Bock, P.E., 2006a. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. J. Biol. Chem. 281, 1169–1178.PubMedCrossRefGoogle Scholar
  55. Panizzi, P., Friedrich, R., Fuentes-Prior, P., Richter, K., Bock, P.E., Bode, W., 2006b. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. J. Biol. Chem. 281, 1179–1187.PubMedCrossRefGoogle Scholar
  56. Petrovan, R.J., Govers-Riemslag, J.W.P., Nowak, G., Hemker, H.C., Tans, G., Rosing, J., 1998. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin. Biochemistry 37, 1185–1191.PubMedCrossRefGoogle Scholar
  57. Phonimdaeng, P., O’Reilly, M., O’Toole, P.W., Foster, T.J., 1988. Molecular cloning and expression of the coagulase gene of Staphylococcus aureus 8325–4. J. Gen. Microbiol. 134, 75–83.PubMedGoogle Scholar
  58. Pijoan, M., 1935. A study on the blood-coagulating substance produced by staphylococci and its relation to disease. Can. Med. Assoc. J. 32, 476–481.PubMedGoogle Scholar
  59. Sawai, T., Tomono, K., Yanagihara, K., Yamamoto, Y., Kaku, M., Hirakata, Y., Koga, H., Tashiro, T., Kohno, S., 1997. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect. Immun. 65, 466–471.PubMedGoogle Scholar
  60. Schwarz-Linek, U., Werner, J.M., Pickford, A.R., Gurusiddappa, S., Kim, J.H., Pilka, E.S., Briggs, J.A., Gough, T.S., Hook, M., Campbell, I.D., Potts, J.R., 2003. Pathogenic bacteria attach to human fibronectin through a tandem β-zipper. Nature 423, 177–181.PubMedCrossRefGoogle Scholar
  61. Seki, K., Ogasawara, M., Sakurada, J., Murai, M., Masuda, S., 1989. Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice. Microbiol. Immunol. 33, 981–990.PubMedGoogle Scholar
  62. Soulier, J.P., Prou-Wartelle, O., 1967. Study of thrombin-coagulase. Thromb. Diath. Haemorrh. 17, 321–334.PubMedGoogle Scholar
  63. Stubbs, M.T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S.R., Bode, W., 1992. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur. J. Biochem. 206, 187–195.PubMedCrossRefGoogle Scholar
  64. Stutzmann Meier, P., Entenza, J.M., Vaudaux, P., Francioli, P., Glauser, M.P., Moreillon, P., 2001. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect. Immun. 69, 657–664.PubMedCrossRefGoogle Scholar
  65. Tager, M., 1948. Studies on the coagulase-reacting factor; the reaction of staphylocoagulase with the components of human plasma. Yale J. Biol. Med. 20, 369–380.PubMedGoogle Scholar
  66. Tager, M., 1956. Studies on the nature and the purification of the coagulase-reacting factor and its relation to prothrombin. J. Exp. Med. 104, 675–686.PubMedCrossRefGoogle Scholar
  67. Tager, M., Drummond, M.C., 1965. Staphylocoagulase. Ann. N.Y. Acad. Sci. 128, 92–111.PubMedCrossRefGoogle Scholar
  68. Tager, M., Hales, H.B., 1948. Properties of coagulase-reacting factor, and relation to blood clotting components. J. Immunol. 60, 1–9.PubMedGoogle Scholar
  69. Watanabe, S., Ito, T., Sasaki, T., Li, S., Uchiyama, I., Kishii, K., Kikuchi, K., Skov, R.L., Hiramatsu, K., 2009. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One 4, e5714.PubMedCrossRefGoogle Scholar
  70. Watanabe, S., Ito, T., Takeuchi, F., Endo, M., Okuno, E., Hiramatsu, K., 2005. Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J. Bacteriol. 187, 3698–3707.PubMedCrossRefGoogle Scholar
  71. Yao, J., Zhong, J., Fang, Y., Geisinger, E., Novick, R.P., Lambowitz, A.M., 2006. Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. RNA 12, 1271–1281.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Peter Panizzi
    • 1
    Email author
  • Heather K. Kroh
    • 2
  • Pablo Fuentes-Prior
    • 3
  • Paul E. Bock
    • 2
  1. 1.Center for Systems BiologyMassachusetts General HospitalBostonUSA
  2. 2.Department of PathologyVanderbilt University School of MedicineNashvilleUSA
  3. 3.Institut de Recerca, Hospital de la Santa Creu i Sant PauBarcelonaSpain

Personalised recommendations